Home › Pulmonary Hypertension › Illinois › Chicago
Pulmonary Hypertension clinical trials in Chicago, IL
5 studies for Pulmonary Hypertension are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Recruiting
- Northwestern University, Chicago
- University of Illinois Health, Chicago
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
RecruitingPhase 3
- Northwestern University, Chicago
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
RecruitingPhase 2
- Clinical Research Site, Chicago
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- Northwestern University, Chicago
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- University of Chicago, Chicago
About Pulmonary Hypertension
Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It makes your heart work harder, which can lead to heart failure.
More about Pulmonary Hypertension on MedlinePlus
Pulmonary Hypertension trials in other cities
- Philadelphia, PA10 studies
- Phoenix, AZ9 studies
- Aurora, CO9 studies
- Kansas City, KS8 studies
- New York City, NY8 studies
- Cincinnati, OH8 studies
- Boston, MA8 studies
- Indianapolis, IN8 studies
- Bend, OR7 studies
- Salt Lake City, UT7 studies
- Houston, TX7 studies
- Rochester, MN7 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.